Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsLivestock-Associated MRSA: The Impact on HumansBacteria from Animals as a Pool of Antimicrobial Resistance Genes.Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistanceEvolving resistance among Gram-positive pathogensOritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results.Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.Presence of the optrA Gene in Methicillin-Resistant Staphylococcus sciuri of Porcine Origin.Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Oxazolidinone antimicrobials: a patent review (2012-2015).Mass spectrometry methods for predicting antibiotic resistance.Linezolid: a promising option in the treatment of Gram-positives.Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin.Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit.Investigation of Linezolid Resistance in Staphylococci and Enterococci.Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance.Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.Linezolid resistance in clinical isolates of Staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids.Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.Commentary: Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.Linezolid-resistant Enterococcus faecalis infection following prolonged low-dosage linezolid treatment for multi-drug-resistant tuberculosis.ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries.Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.Clinical case of cfr-positive MRSA CC398 in Belgium.Mechanisms of Antibiotic Resistance.Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid-Nonsusceptible Vancomycin-Resistant EnterococcusComplete Genome Sequence and Characterization of Linezolid-Resistant Clinical Isolate KUB3006 Carrying a (B)-Transposon on Its Chromosome and -Plasmid
P2860
Q26780246-776F7B73-3C3A-4920-A42B-5D7B06C45363Q26796165-FD97BAA9-03B7-49DF-B0D7-EAC493083E8AQ26799576-AC9CF0A0-03A9-4BDE-B1D4-CB7FD53F675CQ28087717-5D88AB01-83FF-4CD6-9F2C-F6F9C24E2EB1Q33836471-7A48C03D-0A62-436F-B93E-8ABB70C897FDQ33867183-4BA30762-87F2-4BE2-8588-20A9EA421ACFQ35999912-9DC5DA32-F2BB-44F3-A773-89E774B1E54BQ36933484-5C79C89F-B0DB-488E-B78E-86309AEAAD28Q37119083-6678911D-0845-428F-A6F6-F834D408E74AQ37428637-85938AD4-6956-4583-A09A-C382A95B92FBQ37428734-DFF2938C-10DE-4FAD-86D7-E941587981BBQ38352171-10AC2483-7CF2-4F04-94DC-9D854A56F9D0Q38462842-2F187134-6E0B-43AA-BDE3-8201B74996E6Q38777085-484CE155-ACF5-475F-AAB4-89F7FB6943FBQ38783047-AC56898C-3724-47C9-8E94-4A09ADE0ED28Q38867552-C1827FE7-369C-4011-ADB0-A1E5C0BF3A7AQ39044932-0A1B8EC1-E7AE-4B26-B854-86242ECF7979Q40105754-7A9CC1C7-1EB3-414E-9E75-20EB9B28425DQ40209052-0DC732BF-D4B3-4B0E-B5B0-CBB0A3FAE188Q40616680-3D2345B4-54F6-4164-9414-43E022BFCC2FQ40633323-BC5557D7-03B9-45B3-810F-ABDBC98AB74AQ40845477-5076D41A-F5F9-4DC8-AAC2-5C7997CDEC1BQ40873662-58A8E686-B79B-40A9-8BF3-831D575D2029Q41066058-A97F5900-8786-42F6-88B4-B647EE715E59Q41449660-529081F8-B0B6-46F6-A069-8DFD06C2BD69Q41507478-3A74273E-9E9A-4691-8E39-DB590D1FAB23Q41538309-F465B6E4-E600-4F2E-B868-039922371CB6Q41919152-05B5EBD9-1F4C-4E2A-9982-FE2A6AB8252AQ46298851-2DC288C9-E86F-48F8-B4D9-76F1D5927CA0Q47141945-4B603DD1-C8EC-42BF-A228-DE05FABE2CCFQ47577709-EF93B35C-EDBA-4EA9-A5D2-F24F1E185E44Q54415902-DEDBD6E4-0CEB-4489-80A0-AC916FDB8175Q55387439-6A6681EE-2846-4CD7-854F-F9CAA0246759Q57480754-1955216A-E9B7-4618-96A1-48CBE2DB2392Q58556328-6C435249-4963-47E2-A043-8CAF35BE35BF
P2860
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@ast
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@en
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@nl
type
label
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@ast
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@en
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@nl
prefLabel
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@ast
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@en
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@nl
P2093
P1476
Linezolid update: stable in vi ...... ociated resistance mechanisms.
@en
P2093
Lalitagauri M Deshpande
Rodrigo E Mendes
Ronald N Jones
P356
10.1016/J.DRUP.2014.04.002
P577
2014-04-06T00:00:00Z